Fredrik Schjesvold is the founder and Head of Oslo Myeloma Center, in Oslo, Norway. He is head of the Norwegian myeloma association, President of the Nordic Myeloma Study Group and a board member of the European Myeloma Network.
He is principal investigator for 4 academic studies and national investigator of 55 clinical trials in multiple myeloma, in addition to being site investigator in 11 more. He is a co-author of European (ESMO) and global (IMWG) guidelines, as well as lead author of the Norwegian myeloma guidelines. Furthermore, he is peer reviewer of several international journals, and co-editor of the journal Hemato. He is an international expert on myeloma and has given talks in Europe, America and Asia.